For those new to GLP-1 treatments, starting with an easy-to-use format offering sustained effectiveness, like Orforglipron, is a preferable option
Carmot Therapeutics is a U.S.-based biotech company focused on developing incretin-based therapies, including CT-388 (a weekly injectable dual GLP-1/GIP agonist), an oral small-molecule GLP-1 agonist (CT-996), and another injectable GLP-1/GIP candidate (CT-868)
6 Similarly, as GLP-1RAs significantly reduced the risk of MACE, mortality from CV causes, when compared with placebo, ADA has suggested that these medications should be used in patients with underlying cardiovascular disease
Injections can be weekly while refills are made on follow-ups.
These injections have become incredibly popular, but recently, there has been interest in GLP-1 patches as a needle-free alternative
This guide covers everything you need to know about adjusting your GLP-1 dose schedule if you, for any reason, miss your scheduled shot